Services
Precision immunogenicity for every patient.
We serve life science organizations building the next generation of immunotherapies as well as individual patients exploring personalized therapeutic options today.
For Biopharma & Life Sciences
The partner of choice for immunogenicity prediction
Areca Bio serves as the foundational prediction partner for biopharma and life sciences companies running cancer vaccine programs. Our platform integrates seamlessly with existing genomic workflows to deliver superior neoantigen prioritization — across oncology indications and beyond.
We partner at the earliest stages of program design through clinical trial execution, offering co-development arrangements, licensing pathways, and ongoing scientific collaboration.
Explore PartnershipWhat We Offer
Our Approach
For Patients
The path to your most personalized cancer treatment
We believe every cancer patient deserves access to the most precise immunotherapy available. Areca Bio works directly with patients and their care teams to apply our prediction engine to their tumor genomic data — identifying the most immunogenic targets for personalized vaccine design.
Our team guides patients through compassionate use pathways and coordinates with treating oncologists to ensure results are actionable, understandable, and integrated into the broader treatment plan.
Reach Out